NanoViricides Inc. (NNVC)

[drkazmd65]

INO is (indeed) much further along than NNVC - as it has a couple of things in Clinical Testing, and they have some outside licensing for things that could very easily develop into revenue generators as well.

If you look at their share prices back in 2013 - back when they were in a similar situation to NNVC (in not having gotten anything substantial into Clinical testing) they were trading in the ~$2/share ballpark for quite a while.

The finally started to make headway into Clinical testing & they've been has high as close to $15/share.

That's the same kind of gain I think we could see once NNVC gets over the hump and gets HerpesCide (or FluCide for that matter) into Clinical testing.

So - specifically - we could see NNVC with a gain (at least temporarily) to over $10/share once HerpesCide is into Clinical testing. Promising Phase I/II results (presumably in Australia) could boost NNVC even higher.

BUT - it's all dependent on NNVC getting it done.

Hence,... we wait here in the ~$1.50 doldrums of a trading range.